{"summary": "hepatitis B virus is the leading cause of liver cirrhosis and hepatocellular carcinoma in Asia and Africa. glucose-regulated protein 78 (GRP78) can inhibit HBV replication, but promote virion secretion and hepatocellular cancer cell invasion. entecavir and furin inhibitor abolished by entecavir and furin inhibitor respectively. Conclusions GRP78 mainly demonstrates anti-HBV effects, reducing HBV production and HBeAg secretion."}